New fundamental complex in cells drives ‘messy’ form of DNA repair. In immune cells, this is crucial to make antibodies. In cancer, mutations in complex could lead to resistance to BRCA-targeting PARP inhibitor drugs or platinum chemotherapies.
New fundamental complex in cells drives ‘messy’ form of DNA repair. In immune cells, this is crucial to make antibodies. In cancer, mutations in complex could lead to resistance to BRCA-targeting PARP inhibitor drugs or platinum chemotherapies.